Allergy; Dander Clinical Trial
Official title:
Precision Allergy: Separate Allergies to Male and Female Dogs
Verified date | November 2022 |
Source | Copenhagen Studies on Asthma in Childhood |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A new male-specific dog-allergen-component has been found (Can f 5) which indicates possible differences in allergic reactions to male and female dogs. This has not yet been tested in real life. The aim is to test if sensitization only to the male-dog specific allergen-component, Can f 5, results in a positive skin prick test (SPT) to male dog extract and not female dog extract. In addition, the investigators want to investigate if allergic symptoms only occur when exposed to the male dog extract by conjunctival provocation.
Status | Completed |
Enrollment | 22 |
Est. completion date | January 9, 2019 |
Est. primary completion date | September 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 15 Years and older |
Eligibility | Inclusion Criteria: - Participants in the COPSAC 2000 cohort - Positive component test (>0.3 ISU) to Can f 1, Can f 2, Can f 3 or Can f 5 Exclusion Criteria: - Uncontrolled asthma - Eye-surgery within the past 6 months - Antihistamine allergy - and others |
Country | Name | City | State |
---|---|---|---|
Denmark | Copsac, Dbac | Gentofte | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Copenhagen Studies on Asthma in Childhood |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Male vs. female dog SPT in Can f 5 mono sensitized patients | In the patients that have a positive SPT (> 2mm) to dog and are monosensitized to the Can f 5 component, the investigatiors want to compare the reaction to SPT (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures. | 6 months | |
Secondary | Male vs. female dog conjunctival provocation in Can f 5 mono sensitized patients | In the patients that have a positive SPT (> 2mm) to dog and are monosensitized to the Can f 5 component, the investigatiors want to compare the reaction to conjunctival provocation (positive/negative) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures. | 6 months | |
Secondary | Male vs. female dog SPT in dog poly sensitized patients | In the patients that have a positive SPT (> 2mm) to dog and are sensitized to the Can f 1, 2 and/or 3 component, the investigatiors want to compare the reaction to SPT (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures. | 6 months | |
Secondary | Male vs. female dog conjunctival provocation in dog poly sensitized patients | In the patients that have a positive SPT (> 2mm) to dog and are sensitized to the Can f 1, 2 and/or 3 component, the investigatiors want to compare the reaction to conjunctival provocation (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures. | 6 months | |
Secondary | Can f 5 vs. SPT size | To investigate the correlation between specific Immunoglobulin E (sIgE) level to the Can f 5 component and the SPT wheal size to the male dog extract using a general linear model. | 6 months | |
Secondary | Can f 5 vs. conjunctival provocation | To investigate the correlation between sIgE level to the Can f 5 component and the threshold of reaction to the male dog extract at the conjunctival provocation, using a general linear model. | 6 months | |
Secondary | SPT vs. conjunctival provocation | To investigate the correlation between SPT wheal size to the male dog extract and the threshold of reaction to the male dog extract at the conjunctival provocation, using a general linear model. | 6 months |